AIM
AMGN icon

Acrospire Investment Management’s Amgen AMGN Stock Holding History

Acrospire Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$69K – 64
2017
Q2 		$69K Sell
400
-200
-33% -$32.5K 0.06% 539
2017
Q1 		$98K Sell
600
-700
-54% -$116K 0.08% 332
2016
Q4 		$190K Buy
1,300
+200
+18% +$30.1K 0.08% 394
2016
Q3 		$183K Hold
1,100
– – 0.12% 196
2016
Q2 		$167K Sell
1,100
-1,100
-50% -$171K 0.12% 153
2016
Q1 		$330K Buy
+2,200
New +$327K 0.23% 9

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acrospire Investment Management's AMGN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Amgen (AMGN) in Q3 2017, closing a stake of 400 shares — an estimated $69K sold.

Acrospire Investment Management first reported a position in AMGN in Q1 2016 and held it in 6 quarters. The position peaked at $330K in Q1 2016. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 400 Amgen shares in Q3 2017, an estimated $69K.
  • Acrospire Investment Management first reported a position in Amgen in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Amgen position peaked at $330K in Q1 2016.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.